Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Increases By 40.6%

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 804,000 shares, an increase of 40.6% from the February 13th total of 571,900 shares. Based on an average daily trading volume, of 412,700 shares, the short-interest ratio is currently 1.9 days. Currently, 4.9% of the company’s stock are short sold.

Cosmos Health Price Performance

COSM opened at $0.50 on Tuesday. The business’s 50-day moving average is $0.65 and its two-hundred day moving average is $0.75. Cosmos Health has a 1 year low of $0.44 and a 1 year high of $1.58. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. The firm has a market capitalization of $11.72 million, a PE ratio of -0.21 and a beta of 5.60.

Insider Activity

In other news, CEO Grigorios Siokas purchased 257,334 shares of the business’s stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of $0.58 per share, for a total transaction of $149,253.72. Following the completion of the purchase, the chief executive officer now owns 3,774,314 shares in the company, valued at approximately $2,189,102.12. This represents a 7.32 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Georgios Terzis bought 85,778 shares of the business’s stock in a transaction on Friday, December 20th. The stock was bought at an average price of $0.58 per share, for a total transaction of $49,751.24. Following the purchase, the chief financial officer now directly owns 727,263 shares of the company’s stock, valued at $421,812.54. The trade was a 13.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 1,175,618 shares of company stock worth $701,169. Company insiders own 15.61% of the company’s stock.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC raised its stake in Cosmos Health Inc. (NASDAQ:COSMFree Report) by 29.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the period. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 12.61% of the company’s stock.

About Cosmos Health

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.

Featured Articles

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.